As of December 2024, Bliss GVS Pharma has a market cap of $217.50M. This makes Bliss GVS Pharma the world's 16459th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $145.49M | -5.42% |
2023 | $153.82M | 72.17% |
2022 | $89.34M | -30.18% |
2021 | $127.97M | -48.70% |
2020 | $249.46M | 34.14% |
2019 | $185.97M | -8.67% |
2018 | $203.62M | -22.17% |
2017 | $261.62M | 36.12% |
2016 | $192.20M | -11.53% |
2015 | $217.25M | 177.46% |
2014 | $78.30M | 52.89% |
2013 | $51.21M | -2.47% |
2012 | $52.51M | 100.71% |
2011 | $26.16M | -38.55% |
2010 | $42.57M | - |